Erez Raphael - 11 Sep 2025 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: DRIO
Reported as of: 11 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Sep 2025, 16:08:08 UTC
Prior SEC filing: 28 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ Erez Raphael

Key filing fact

Erez Raphael filed Form 4 for DarioHealth Corp. (DRIO) on 15 Sep 2025.

Key facts

This page summarizes Erez Raphael's Form 4 filing for DarioHealth Corp. (DRIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Sep 2025, 16:08.

Change

Previous filing in this sequence was filed on 28 Aug 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001668046 Primary reporting owner

Raphael Erez

Relationship: Chief Executive Officer, Director
Address: 322 W 57TH STREET, #33B, NEW YORK
Signature: /s/ Erez Raphael
Signature date: 15 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DRIO transaction

Common Stock

Award

Transaction value: $0
Shares: +60,000
Change %: +62%
Price: $0.000000
Shares after: 156,853
Date: 11 Sep 2025
Ownership: Direct
Footnotes: F1, F2

DRIO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,894
Date: 11 Sep 2025
Ownership: By Dicilyon Consulting and Investment Ltd.
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period.

Footnote F2

The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.